Auron Therapeutics

Developer of cancer therapeutics for the treatment of blood cancer

placeWellesley, Massachusetts, United States calendar_todayFounded 2018 groups27 employees language aurontx.com

Social engagement

Social engagement: 3.6K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

14 investors on record; lead investors include Creyon Bio, Totus Medicines, Genedit, Mubadala.

Investor typeCountShare
Venture capital750%
Private equity17%
Other / undisclosed643%

Recent activity

22 Jan 2026
Event
Keystone Symposia on Molecular & Cellular Biology Cancer Cell Symposium
3 Nov 2025
Event
International Workshop on Differentiation Syndrome (iwDS)
13 Oct 2025
Event
8th Annual Targeted Protein Degradation (TPD) & Induced Proximity Summit
Coming soon